Sensex rises for fourth day; jumps 4.5 percent in Nov
MUMBAI (Reuters) - The BSE Sensex ended higher for the fourth day in a row after weak GDP data raised hopes of some monetary easing at the next RBI meeting on December 18.
The Indian economy extended its long slump in the quarter ending in September with lower-than-expected growth at 5.3 percent keeping it on track for its worst year in a decade.
Markets will closely track the vote on foreign investment in multi-brand retail in parliament and manufacturing PMI for November next week. Market participants say stocks may extend gains if the vote goes in favour of the government.
"It really depends on the Parliament vote now. If it goes through, there will be a boost to confidence. If it doesn't, it may indicate less aggression on reforms from the government," said Sonam Udasi, head of research at IDBI Capital.
The BSE Sensex ended up 0.88 percent, or 168.99 points, at 19,339.90, its highest close since April 27, 2011, gaining 4.5 percent for the week.
For the month, the BSE Sensex rose 4.51 percent; Nifty added 4.63 percent.
The 50-share NSE index gained 0.94 percent, or 54.85 points, to 5,879.85, its highest close since April 21, 2011, also adding 4.5 percent for the week.
Both the indexes have posted their best weekly gains since the week ending June 8 on rising expectations of reform and measures to contain India's twin deficit and FII inflow along with Moody's stable outlook on India and after Goldman Sachs upgraded Indian equities.
Andrew Swan, who manages about $3 billion as the head of Asian equities for BlackRock, told the Reuters Global Investment 2013 Outlook Summit on Friday that Indian politicians will push reforms and economic growth will tick up.
State Bank of India rose 1.8 percent and Punjab National Bank (PNBK.NS) gained 2.37 percent after data showed farming output has grown 1.2 percent in the September quarter, as both banks have substantial farm loan exposure.
Indian banks have seen a pick-up in demand for credit since the beginning of the festive season in October and are confident of meeting the central bank's projection for the fiscal year ending in March 2013.
ICICI Bank (ICBK.NS) rose 1.67 percent, while Union Bank (UNBK.NS) was up 3.74 percent.
Recent underperformers, that missed the week's rally, gained on Friday. Shares of Oil and Natural Gas Corp (ONGC) rose 4.4 percent, while capital goods major Bharat Heavy Electricals Ltd (BHEL.NS) gained 5.5 percent.
Shares in drugmaker Cipla rose 2.5 percent after Cipla Medpro CMPJ.J won a share in South Africa's $667 million contract, as it supplies the bulk of Cipla Medpro's drugs.
South Africa on Thursday awarded a $667 million contract to supply life-prolonging HIV medicine to 12 international and domestic firms, including Cipla Medpro, to deal with its biggest health problem.
Bharti Airtel (BRTI.NS) shares rose 2 percent.
Bharti Infratel Ltd, the telecommunications tower unit of Bharti Airtel is set to raise up to $825 million next month in what would be the country's biggest initial share offering in two years.
Shares in HCL Technologies Ltd (HCLT.NS) rose 2.8 percent after the company said it signed a five-year, multi-million dollar transformational engineering services agreement with Manitowoc Cranes.
However, among the stocks that fell, shares in Idea Cellular dropped 2.4 percent on profit-taking after rising 16.12 percent in November as of Thursday's close, versus a gain of 3.6 percent in the NSE index.
Dealers say the reduction in regulatory uncertainty after lower-than-expected receipts in the 2G auction helped the stock gain in November but it is priced in.
(Editing by Anupama Dwivedi)
- Tweet this
- Share this
- Digg this
- Wal-Mart and allies in face-off with Apple Pay over mobile payments
- Hundreds of Iraqi tribesmen opposed to Islamic State found in mass graves
- India's universal healthcare rollout to cost $26 billion
- PM Modi boots officials out of the first class cabin
- Sensex, Nifty hit record highs, shrug off Fed's hawkish tone
India's universal health plan that aims to offer guaranteed benefits to a sixth of the world's population will cost an estimated 1.6 trillion rupees ($26 billion) over the next four years, a senior health ministry official said. Full Article